Dr. Ewa Totoń has studied at Poznan University of Medical Sciences since 1996. Currently, she is a researcher at the Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, and a member of Błażej Rubiś’s lab. She is also a member of the Scientific Committee at the Poznan University of Medical Sciences. Her skills and expertise mainly include apoptosis, cell signaling, signal transduction, cell culture, cancer biology, cell proliferation, gene expression, Western blot analysis, molecular cell biology, and immunofluorescence staining.
Professor Błażej Rubiś graduated in the field of biotechnology at the University of Life Sciences in Poznań in 2000 and started working at the Medical University of Poznan within the Department of Biochemistry and Molecular Biology. In 2005, he moved to the Department of Pharmaceutical Biochemistry of the Medical University of Poznań, and a year later he defended his doctorate in biological sciences. During this period (2008–2009), he received a Polish–Austrian government scholarship and spent 3 months at the Biocentrum of the Medical University of Innsbruck in Austria. Since 2008, he has been working at the Department of Clinical Chemistry and Molecular Diagnostics, and since 2016, he has been the head of this department. In 2014, he completed a 2-year postdoctoral fellowship in cancer molecular genetics at Brown University, Department of Pathology and Laboratory Medicine, Providence, RI, USA. In 2020, he received the title of professor from the president of the Republic of Poland. The main goal of research work in the laboratory headed by him is to study the molecular mechanisms related to carcinogenesis to find more effective ways to eliminate cancer cells. In particular, his areas of interest include telomeres and telomerase, as well as cell death and drug resistance. His current research focuses on the link between telomerase expression and activity and the metastatic potential of cancer cells.
